Scientists identify measurable cellular changes that flag higher cancer risk more than a decade before tumors appear. In ...

As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain ...

Organoids refer to small-scale organs made up of diverse cell types, exhibiting structures and functions akin to actual organs. Unlike conventional cell cultures, organoids better replicate human ...

One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet ...

Fatty liver disease isn’t just a concern for the overweight—it can strike people of healthy weight and diet, and now scientists think they know why. Two genes previously linked to cancer, RNF43 and ...

A fatty diet doesn’t just damage the liver — it rewires its cells in ways that give cancer a dangerous head start.

Researchers from Miguel Hernández University of Elche (UMH) in Spain have identified an effective strategy to reduce ...

Drugs that fail in late stages of development create one of the biggest challenges in global healthcare. In fact, less than 10% of the drugs that move into clinical development survive to approval.

The U.S. Food and Drug Administration has qualified the first AI tool designed to help doctors assess a severe form of fatty liver disease in drug trials.

The FDA has qualified AI-Based Histologic Measurement of MASH, or AIM-MASH AI Assist — the first AI drug development tool — ...